Company Search:
Advanced Search
Sponsored Links
Medibio Ltd Company Snapshot
Medibio Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medibio Ltd with three other companies in this sector in AUSTRALIA : Pharmaust Limited (2019 sales of 4.36 million Australian Dollars [US$3.12 million] ), Noxopharm Ltd (3.94 million Australian Dollars [US$2.81 million] ), and Avecho Biotechnology Ltd (4.24 million Australian Dollars [US$3.03 million] ).

Sales Analysis. Medibio Ltd reported sales of A$4.13 million (US$2.95 million) for the fiscal year ending June of 2019. This represents an increase of 58.9% versus 2018, when the company's sales were A$2.60 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medibio Ltd
  Stock Performance Chart for Medibio Ltd
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): .01
(Figures in Australian Dollars)
1 Week -35.3%   13 Weeks 69.2%  
4 Weeks 57.1%   52 Weeks -42.1%  
Medibio Ltd Key Data:
  Ticker: MEB Country: Australia
  Exchanges: BLN ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 4,132,291
(Year Ending Jan 2020).
Employees: 4
  Currency: Australian Dollars Market Cap: 11,268,716
  Fiscal Yr Ends: June Shares Outstanding: 1,024,428,697
  Share Type: Ordinary Closely Held Shares: 167,053,099
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.